A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer

Cancer Research

Volumn 68, Issue 19, 2008, Pages 8113-8121

  Guerra, Emanuela ^a,b   Trerotola, Marco ^a,b   Dell'Arciprete, Roberta ^b   Bonasera, Veronica ^a   Palombo, Barbara ^a,b   El Sewedy, Tarek ^b,c   Ciccimarra, Tommaso ^b   Crescenzi, Carlo ^b   Lorenzini, Franco ^b   Rossi, Cosmo ^a,b   Vacca, Giovanna ^a,b   Lattanzio, Rossano ^a   Piantelli, Mauro ^a   Alberti, Saverio ^a,b  

^a UNIVERSITY OF CHIETI   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c KING ABDULAZIZ CITY FOR SCIENCE AND TECHNOLOGY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; EPITHELIAL CELL ADHESION MOLECULE; MESSENGER RNA; PROTEIN TROP 2; RAS PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHIMERA; CONTROLLED STUDY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; RNA TRANSLATION; TUMOR GROWTH;

ANIMALS; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CELL ADHESION MOLECULES; CELL TRANSFORMATION, NEOPLASTIC; CERCOPITHECUS AETHIOPS; COS CELLS; FEMALE; GENES, BCL-1; HUMANS; MICE; MICE, INBRED C57BL; MICE, NUDE; ONCOGENE PROTEINS, FUSION; OVARIAN NEOPLASMS; PROTEIN BIOSYNTHESIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 54249114979     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-6135     Document Type: Article

References (45)

1. Fornaro M, Dell'Arciprete R, Stella M, et al. Cloning of the gene encoding TROP-2, a cell-surface glycoprotein expressed by human carcinomas. Int J Cancer 1995;62:610-8.
2. Calabrese G, Crescenzi C, Morizio E, Palka G, Guerra E, Alberti S. Assignment of TACSTD1 (alias TROP1, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias TROP2, M1S1) to human chromosome 1p32 by in situ hybridization. Cytogenet Cell Genet 2001;92:164-5.
3. Linnenbach AJ, Wojcierowski J, Wu SA, et al. Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733. Proc Natl Acad Sci U S A 1989;86:27-31.
4. Klein CE, Hartmann B, Schön MP, Weber L, Alberti S. Expression of 38-kD cell-surface glycoprotein in transformed human keratinocyte cell lines, basal cell carcinomas, and epithelial germs. J Invest Dermatol 1990;95:74-82.
5. Ripani E, Sacchetti A, Corda D, Alberti S. The human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer 1998;76:671-6.
6. Zanna P, Trerotola M, Vacca G, et al. Trop-1 is a novel cell growth stimulatory molecule that marks early stages of tumor progression. Cancer 2007;110:452-64.
7. El-Sewedy T, Fornaro M, Alberti S. Cloning of the mouse Trop2 gene - conservation of a PIP2-binding sequence in the cytoplasmic domain of Trop-2. Int J Cancer 1998;75:324-31.
8. Balzar M, Briaire-de Bruijn IH, Rees-Bakker HAM, et al. Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions. Mol Cell Biol 2001;21:2570-80.
9. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K, Mori M. Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 2006;12:3057-63.
10. Basu A, Goldenberg DM, Stein R. The epithelial/carcinoma antigen EGP-1, recognized by monoclonal antibody RS7-3G11, is phosphorylated on serine 303. Int J Cancer 1995;62:472-9.
11. Raynaud SD, Bekri S, Leroux D, et al. Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies. Genes Chromosomes Cancer 1993;8:80-7.
12. Novo FJ, de Mendibil IO, Vizmanos JL. TICdb: a collection of gene-mapped translocation breakpoints in cancer. BMC Genomics 2007;8:33.
13. Mitelman F. Recurrent chromosome aberrations in cancer. Mutat Res 2000;462:247-53.
14. Motokura T, Arnold A. PRAD1/ cyclin D1 protooncogene: genomic organization, 5′ DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chromosomes Cancer 1993;7:89-95.
15. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A 1994;91:709-13.
16. Lebwohl DE, Muise Helmericks R, Sepp Lorenzino L, et al. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene 1994;9:1925-9.
17. Bringuier PP, Tamimi Y, Schuuring E, Schalken J. Expression of cyclin D1 and EMS1 in bladder tumors; relationship with chromosome 11q13 amplification. Oncogene 1996;12:1747-53.
18. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein IB. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 1992;52:2980-3.
19. Johnson JM, Castle J, Garrett-Engele P, et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003;302:2141-4.
20. Buratti E, Baralle M, Baralle FE. Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic Acids Res 2006;34:3494-510.
21. Pajares MJ, Ezponda T, Catena R, Calvo A, Pio R, Montuenga LM. Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol 2007;8:349-57.
22. Paushkin SV, Patel M, Furia BS, Peltz SW, Trotta CR. Identification of a human endonuclease complex reveals a link between tRNA splicing and pre-mRNA 3′ end formation. Cell 2004;117:311-21.
23. Back SH, Lee K, Vink E, Kaufman RJ. Cytoplasmic IRE1α-mediated XBP1 mRNA splicing in the absence of nuclear processing and endoplasmic reticulum stress. J Biol Chem 2006;281:18691-706.
24. Murphy WJ, Watkins KP, Agabian N. Identification of a novel Y branch structure as an intermediate in trypanosome mRNA processing: evidence for trans splicing. Cell 1986;47:517-25.
25. Zhang H, Hou Y, Miranda L, et al. Spliced leader RNA trans-splicing in dinoflagellates. Proc Natl Acad Sci U S A 2007;104:4618-23.
26. Horiuchi T, Aigaki T. Alternative trans-splicing: a novel mode of pre-mRNA processing. Biol Cell 2006;98:135-40.
27. Vellard M, Soret J, Viegas-Pequignot E, et al. C-myb proto-oncogene: evidence for intermolecular recombination of coding sequences. Oncogene 1991;6:505-14.
28. Zhang C, Xie Y, Martignetti JA, Yeo TT, Massa SM, Longo FM. A candidate chimeric mammalian mRNA transcript is derived from distinct chromosomes and is associated with nonconsensus splice junction motifs. DNA Cell Biol 2003;22:303-15.
29. Ng P, Wei CL, Sung WK, et al. Gene identification signature (GIS) analysis for transcriptome characterization and genome annotation. Nat Methods 2005;2:105-11.
30. Orsulic S, Li Y, Soslow RA, Vitale-Crosss LA, Gutkind JS, Varmus HE. Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell 2002;1:53-62.
31. Resnitzky D. Ectopic expression of cyclin D1 but not cyclin E induces anchorage-independent cell cycle progression. Mol Cell Biol 1997;17:5640-7.
32. Giavazzi R, Garofalo A. The nude mouse for the study of human colorectal carcinoma. Adv Exp Med Biol 1988;233:39-47.
33. Romani A, Guerra M, Trerotola M, Alberti S. Detection and analysis of spliced chimeric mRNAs in sequence databanks. Nucleic Acids Res 2003;31:1-8.
34. Motokura T, Bloom T, Kim HG, et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 1991;350:512-5.
35. Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007;318:1108-13.
36. Xiong Y, Connolly T, Futcher B, Beach D. Human D-type cyclin. Cell 1991;65:691-9.
37. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992;89:5547-51.
38. Savant-Bhonsale S, Cleveland DW. Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a >20S degradation complex. Genes Dev 1992;6:1927-39.
39. Terrinoni A, Dell'Arciprete R, Fornaro M, Stella M, Alberti S. The Cyclin D1 gene contains a cryptic promoter that is functional in human cancer cells. Genes Chromosomes Cancer 2001;31:209-20.
40. Bates S, Peters G. Cyclin D1 as a cellular protooncogene. Semin Cancer Biol 1995;6:73-82.
41. Pusch O, Soucek T, Wawra E, Hengstschlager-Ottnad E, Bernaschek G, Hengstschlager M. Specific transformation abolishes cyclin D1 fluctuation throughout the cell cycle. FEBS Lett 1996;385:143-8.
42. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammar y hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994;369:669-71.
43. van Erp PE, Boezeman JB, Brons PP. Cell cycle kinetics in normal human skin by in vivo administration of iododeoxyuridine and application of a differentiation marker-implications for cell cycle kinetics in psoriatic skin. Anal Cell Pathol 1996;11:43-54.
44. Alberti S, Miotti S, Stella M, et al. Biochemical characterization of Trop-2, a cell surface molecule expressed by human carcinomas: formal proof that the monoclonal antibodies T16 and MOv-16 recognize Trop-2. Hybridoma 1992;11:539-45.
45. Lin DI, Barbash O, Kumar KG, et al. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-αB crystallin) complex. Mol Cell 2006;24:355-66.